ResearcherUniversity of Colorado Cancer CenterNo recent work listed
Rajesh Agarwal
Matched on ORCID iD 0000-0002-9455-0235; OpenAlex author ID A5048444823; NIH RePORTER profile ID 1865330. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 1
- Labs led
- 2
- Collaborators
- 6
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers, 1 grant · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 6
- Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (Momordica charantia) against Pancreatic Cancer. Last author DOI 10.15430/jcp.2021.26.4.266↗
- Bitter melon juice-intake modulates glucose metabolism and lactate efflux in tumors in its efficacy against pancreatic cancer. Last author DOI 10.1093/carcin/bgz114↗
- Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Last author DOI 10.1002/mc.22833↗
- Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention. Last author DOI 10.2174/0929867324666170320120647↗
- Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells. Last author DOI 10.3892/ijo.2015.2885↗
- In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells. Co-author DOI 10.1016/j.canlet.2012.09.004↗
Grants 1
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Deepanshi Dhar · 3 shared papers, 2018–2019 · strength 0.33
- Paper Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention. DOI 10.2174/0929867324666170320120647↗
- Paper Bitter melon juice-intake modulates glucose metabolism and lactate efflux in tumors in its efficacy against pancreatic … DOI 10.1093/carcin/bgz114↗
- Paper Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. DOI 10.1002/mc.22833↗
- Gagan Deep · 2 shared papers, 2015–2018 · strength 0.15
- Kushal Kandhari · 1 shared paper, 2021 · strength 0.14
- Ranganatha R. Somasagara · 1 shared paper, 2015 · strength 0.06
- Dhanya K. Nambiar · 1 shared paper, 2013 · strength 0.05
- Rana Pratap Singh · 1 shared paper, 2013 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.